glp-1 cost reduction The of manufacturing anti-obesity drugs is low The GLP-1 Access Gap: Mapping
Description
Available from: Brittany V B Johnson 1 , Mary Milstead 1 , Rachel Kreider 1 , Rachel Jones 1 Dietary supplement considerations during glucagon-like Peptide-1 receptor agonist treatment: A narrative review
It can also help lower and control blood sugar levels by enhancing insulin release and reducing the speed at which sugar is absorbed into the bloodstream
State drug utilization data
It mimics the effects of the GLP-1 hormone, which helps to increase insulin secretion, decrease glucagon levels, and slow gastric emptying to improve glycemic control
